Since the publication of the 2018 European Society of Cardiology/European Society of
Hypertension (ESC/ESH) Guidelines for the Management of Arterial Hypertension, several …

Background Renal denervation has been shown to lower blood pressure in the presence of
antihypertensive medications; however, long-term safety and efficacy data from randomised …

Importance Two initial sham-controlled trials demonstrated that ultrasound renal denervation
decreases blood pressure (BP) in patients with mild to moderate hypertension and …

Background: Whether and to what extent the reported blood pressure (BP) lowering effects
of renal denervation (RDN) are associated with a central sympathoinhibition is controversial …

Importance Ultrasound renal denervation (uRDN) was shown to lower blood pressure (BP)
in patients with uncontrolled hypertension (HTN). Establishing the magnitude and …

Importance Although early trials of endovascular renal denervation (RDN) for patients with
resistant hypertension (RHTN) reported inconsistent results, ultrasound RDN (uRDN) was …

BACKGROUND: The randomized, sham-controlled RADIANCE-HTN (A Study of the Recor
Medical Paradise System in Clinical Hypertension) SOLO, RADIANCE-HTN TRIO, and …

Supported by several high-quality randomized controlled trials and registry analyses,
catheter-based renal denervation is becoming an important adjunctive treatment modality for …

BACKGROUND: Renal denervation (RDN) can lower blood pressure (BP) in patients with
hypertension in both the presence and absence of medication. This is a sham-controlled trial …

BACKGROUND: Several sham-controlled trials have investigated the efficacy and safety of
catheter-based renal denervation (RDN) with mixed outcomes. We aimed to perform a …